Does Extent of Resection Impact Survival in Patients Bearing Glioblastoma?
暂无分享,去创建一个
David Fortin | David Mathieu | D. Mathieu | P. Goffaux | D. Fortin | N. Dea | Philippe Goffaux | Nicolas Dea | Marie-Pierre Fournier-Gosselin | M. Fournier-Gosselin
[1] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[2] W. Mason,et al. Canadian recommendations for the treatment of glioblastoma multiforme , 2007, Current oncology.
[3] D. Silbergeld,et al. Early postoperative magnetic resonance imaging following nonneoplastic cortical resection. , 1996, Journal of neurosurgery.
[4] Klaus Sartor,et al. Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma: Objective Evaluation of Residual Tumor and Its Influence on Regrowth and Prognosis , 1995 .
[5] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[6] K Sartor,et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. , 1994, Neurosurgery.
[7] M. Berger,et al. GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME , 2008, Neurosurgery.
[8] M. Berger,et al. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. , 1999, Surgical neurology.
[9] I. Elmaci,et al. Early-postoperative magnetic resonance imaging in glial tumors: prediction of tumor regrowth and recurrence. , 2003, European journal of radiology.
[10] Henry Brem,et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.
[11] L. Hesson,et al. Epigenetic markers in human gliomas: prospects for therapeutic intervention , 2008, Expert review of neurotherapeutics.
[12] D. Fortin. Altering the properties of the blood-brain barrier: disruption and permeabilization. , 2003, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[13] N. de Tribolet,et al. Malignant glioma: should chemotherapy be overthrown by experimental treatments? , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] Marie-Hélène Boudrias,et al. Enhanced chemotherapy delivery by intraarterial infusion and blood‐brain barrier disruption in malignant brain tumors , 2005, Cancer.
[15] Christos Trantakis,et al. Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme—a quantitative radiological analysis , 2005, Neuroradiology.
[16] M. Walker. The contemporary role of chemotherapy in the treatment of malignant brain tumor. , 1978, Clinical neurosurgery.
[17] Tarik Tihan,et al. Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. , 2006, Journal of neurosurgery.
[18] K. Stein,et al. Temozolomide for high grade glioma. , 2008, The Cochrane database of systematic reviews.
[19] Paul S Mischel,et al. MR imaging correlates of survival in patients with high-grade gliomas. , 2005, AJNR. American journal of neuroradiology.
[20] P. Gutin,et al. Neuro-oncology: diagnosis and management of cerebral gliomas--past, present, and future. , 2000, Neurosurgery.